HISA QLD: Precision and Personalised Medicine with AI - a Queensland Case Study
Tell a Friend About This EventTell a Friend
HISA QLD: Precision and Personalised Medicine with AI - a Queensland Case Study

8/10/2018
When: Monday 8 October 2018
5:00pm - 7:00pm
Where: The Precinct
Level 2
315 Brunswick Street
Fortitude Valley, Queensland  4006
Australia
Contact: Sharlene Gunatilake
03 9326 3311


Online registration is closed.
« Go to Upcoming Event List  

HISA QLD - Precision and personalised medicine with AI – a Queensland case study

Precision medicine brings together existing and new data, human skill, data analytics and compute capability to explore complex patterns of disease.  This will result in better, more tailored treatments, healthier populations and a more efficient and effective health system.

Come and hear Nicholas Therkelsen-Terry, CEO & co-founder of a Brisbane-based data analytics and artificial intelligence company, Max Kelsen, who have been awarded a $2.6 million CRC-P grant.  Working alongside genomiQa, QIMR, BGI and QLD Health Metro North Hospital and Health Service, Max Kelsen plans to integrate artificial intelligence and whole-genome sequencing into cancer research and clinical practice.

This project will see genomic data combined with AI technologies to predict patient responses to cancer treatments.  The collaboration of technology researchers at Max Kelsen with world-class health researchers is poised to push the fields of artificial intelligence and cancer research forward.


Followed by an interactive panel discussion addressing the broader implications for healthcare, potential in prediction and prevention and the ethical and social impacts of AI.

 

Speaker

Nicholas Therkelsen-Terry CEO and Co-founder, Max Kelsen and cognitiveCX

Panel

 

Facilitator
Kathy Campbell Director, Ockham Consulting Pty Ltd

Kathy Campbell has held executive roles in healthcare over the past 20 years with providers, consulting firms and vendors in Australia and overseas, including as IM & ICT Project Director for the Victorian Comprehensive Cancer Centre and as CIO of UnitingCare Health. Kathy now provides consulting assistance to organisations such as Melbourne Genomics Health Alliance, Queensland Genomics Health Alliance, Queensland Health and the Australian Commission on Safety and Quality in Health Care. She is also a Non-Executive Director of Brisbane North Primary Health Network and Uniting AgeWell (Vic/Tas).
  A/Prof Andrew Crowden
Associate Professor, School of Historical and Philosophical Inquiry, The University of Queensland 
Andrew Crowden is a practical ethicist and bioethicist with extensive experience in clinical, research and organisational ethics.  He is Associate Professor in Philosophy at the University of Queensland’s School of Historical and Philosophical Inquiry and has a Ph.D. and Master degrees from the Bioethics Centre at Monash University. Andrew is Chairperson of the University of the Sunshine Coast HREC, a member of the Australian Institute of Aboriginal and Torres Strait Islander Studies Research Ethics Committee and Research Ethics Stream Leader for the Australasian Association of Bioethics and Health Law. Andrew is an active researcher and is a Chief Investigator for several interdisciplinary research projects in collaboration with a range of industry and university partners. His research in philosophy, ethics and genomics is funded by the University of Queensland, the Queensland Genomic Health Alliance and the John Templeton Foundation in collaboration with the University of Virginia and QIMR Berghofer Medical Research Institute.
  David Bunker Executive Director, Queensland Genomics Health Alliance David Bunker is the Executive Director of the Queensland Genomics Health Alliance. He has a commitment to health and social outcomes, and values-based business transformation. His commitments include significant voluntary contribution to NFP Boards, Graduate Business Schools, as well as Professional Societies and Academic Colleges. His current focus with the Queensland Genomics Health Alliance is to fast track genomics research and its translation into common healthcare practice, while building a sound, evidence-based decision making framework for strategic capability and capacity building programs within the health system.
 

A/Prof Damian Hine 
Acting Director, Australian Institute for Business and Economics 

Damian is an evolutionary economist focussed on innovations that enhance firm growth and economic development.  At the core of Damian’s work is the creation, development and uptake of new ideas and technologies and the business model innovation needed to support them. His research employs novel quantitative modelling techniques on large data sets, as well as community level interventions aimed at increasing the innovativeness of businesses, communities and industries.  His work on biotechnology innovation has been published in Nature Reviews Drug Discovery, Trends in Biotechnology, and Health Affairs. Damian has also published commissioned national and international reports on Australia’s Biotechnology industry competitiveness for the McKell Institute; advanced manufacturing opportunities in Asia for Telstra; and the future of the biotechnology industry for the OECD.
 

Prof Matt Bellgard
Director eResearch, Division of Research and Commercialisation, University of Queensland

Professor Matt Bellgard has a PhD in Computer Science from the University of Western Australia (1994), specialising in Artificial Intelligence. He is the inaugural eResearch Director at Queensland University of Technology (March 2018 – present). To date, he has personally attracted over $44m in research funding, co-inventor of 5 full/20 provisional patents, designed and commissioned a world’s top 100 supercomputer, co-authored over 139 peer reviewed articles in areas including health informatics, bioinformatics and genomics. He has led the design and development of digital health solutions for government, industry and academia, addressing policy, privacy, consent issues across multiple jurisdictions. Professor Bellgard is now a Board member of the APEC Life Science Innovation Forum Executive Board and Chair of the APEC LSIF Rare Disease Network. 

 

Fee

Members FREE
Non-members $25

CPD Points

This event has been approved for up to 1.5 contact hours of continuing education credit toward renewal of the CHIA credential. Click here for more information on becoming a certified health informatics professional.

Sign In
Login with LinkedIn
OR


Job search
Submit a job
Subscribe for job alerts